DSpace Repository

Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir

Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir

Manosuthi W.; Sungkanuparph S.; Ruxrungtham K.; Prasithsirikul W.; Athichathanabadi C.; Tantisiriwat W.; Bowonwatanuwong C.; Chumpathat N.; Chaovavanich A.
URI: https://ir.swu.ac.th/jspui/handle/123456789/14896
https://www.scopus.com/inward/record.uri?eid=2-s2.0-39049117418&doi=10.1097%2fQAI.0b013e318157b0da&partnerID=40&md5=9c6cb1be2c5626aefcfeb310a21297cf
Date: 2008

Abstract:

[No abstract available]

Show full item record

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account

Statistics